This is a study in adults with geographic atrophy, an advanced form of age-related macular
degeneration. The purpose of this study is to find out how well different doses of BI 754132
The participants are in the study for about 4 months. During this time, they visit the study
site about 10 times. Participants receive 1 injection of BI 754132 directly into one of the
eyes affected by geographic atrophy. In this study, BI 754132 is given to humans for the
The doctors compare how well participants tolerate the different doses of BI 754132. The
doctors also regularly check the general health of the participants.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.